RCT: randomized control trial; T2DM: type 2 diabetes mellitus; OHAs: oral hypoglycemic drugs; DPP4 inhibitor: dipeptidyl peptidase 4 inhibitor. Here, DPP4 is linked to diabetes mellitus.